Jack Phillips - May 29, 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Executive Officer, Director
Signature: /s/ David Patience, attorney-in-fact
Stock symbol: AXDX
Transactions as of: May 29, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/30/2024, 04:25 PM
Previous filing: Apr 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Award	$0	+360K		$0.00	360K	May 29, 2024	Common Stock	360K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2	On May 29, 2024, the reporting person was granted a total of 360,000 RSUs, of which 40% vest on May 29, 2026 and the remaining 60% vest on May 29, 2027.